ARCON：联合使用卡波金和烟酰胺的加速放射疗法。 - Suppr

Suppr

超能文献

ARCON: accelerated radiotherapy with carbogen and nicotinamide.

作者信息

Rojas A

机构信息

Gray Laboratory, Mount Vernon Hospital, Northwood, Middlesex, UK.

出版信息

BJR Suppl. 1992;24:174-8.

PMID:1290695

Abstract

摘要

相似文献

ARCON: accelerated radiotherapy with carbogen and nicotinamide.ARCON：联合使用卡波金和烟酰胺的加速放射疗法。

BJR Suppl. 1992;24:174-8.

Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.在小鼠乳腺癌中使用传统放疗和加速放疗时，二氧化碳和烟酰胺作为放射增敏剂的研究

Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):357-65. doi: 10.1016/0360-3016(95)02087-x.

ARCON: a novel biology-based approach in radiotherapy.ARCON：放射治疗中一种基于生物学的新方法。

Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4.

[The effect of nicotinamide and carbogen on the radiation tolerance of the spinal cord of the rat].[烟酰胺和卡波金对大鼠脊髓辐射耐受性的影响]

Strahlenther Onkol. 1994 Nov;170(11):674-5.

ARCON--current status: summary of a workshop on preclinical and clinical studies.加速康复外科（ARCON）——当前状况：临床前与临床研究研讨会综述

Acta Oncol. 1997;36(5):517-25. doi: 10.3109/02841869709001308.

Nicotinamide and carbogen: major effect on the radiosensitivity of EMT6 and HRT18 tumours.烟酰胺与混合气体：对EMT6和HRT18肿瘤放射敏感性的主要影响。

Radiother Oncol. 1993 Sep;28(3):203-7. doi: 10.1016/0167-8140(93)90059-h.

Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.在单次和多次照射期间，通过卡波金和烟酰胺增强肿瘤灌注和氧合作用。

Radiat Res. 2000 Jan;153(1):75-83. doi: 10.1667/0033-7587(2000)153[0075:eotpao]2.0.co;2.

Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.烟酰胺、全氟三丙胺乳剂和富氧空气：一种在体内使急性和慢性缺氧细胞复氧的策略。

Br J Cancer. 1991 Jan;63(1):109-13. doi: 10.1038/bjc.1991.22.

Efficacy of agents counteracting hypoxia in fractionated radiation regimes.分次放疗方案中抗缺氧药物的疗效

Radiother Oncol. 1996 Nov;41(2):143-9. doi: 10.1016/s0167-8140(96)01787-2.

Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.从高压氧到加速放疗、卡波金和烟酰胺的乏氧细胞放射增敏的临床结果。

Br J Cancer Suppl. 1996 Jul;27:S271-8.

引用本文的文献

Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.烟酰胺的多种治疗功效和更多样化的作用机制。

Metabolomics. 2019 Oct 5;15(10):137. doi: 10.1007/s11306-019-1604-4.

Use of power Doppler ultrasound-guided biopsies to locate regions of tumour hypoxia.使用能量多普勒超声引导活检来定位肿瘤缺氧区域。

Br J Cancer. 1997;76(10):1308-14. doi: 10.1038/bjc.1997.553.

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.卡波金和烟酰胺在根治性放射治疗膀胱癌中的应用

Br J Cancer. 1997;76(2):260-3. doi: 10.1038/bjc.1997.372.

The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging.通过梯度回波磁共振成像监测实验性肿瘤模型中对卡波金呼吸的反应。

Br J Cancer. 1997;75(7):1000-6. doi: 10.1038/bjc.1997.172.

Br J Cancer Suppl. 1996 Jul;27:S271-8.

Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content.肿瘤和皮下小动脉的小动脉氧合：吸入气氧含量的影响。

Br J Cancer Suppl. 1996 Jul;27:S241-6.

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.不同剂量烟酰胺的药代动力学以及联合使用卡波金和烟酰胺进行肿瘤放射增敏：临床考量

Br J Cancer. 1993 Dec;68(6):1115-21. doi: 10.1038/bjc.1993.490.

Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.卡波金和烟酰胺单独及联合使用后RIF-1肿瘤及正常组织中的灌注变化。

Br J Cancer. 1995 Jun;71(6):1175-80. doi: 10.1038/bjc.1995.229.

Clinical significance of cellular resistance in tumours to cytotoxic chemotherapy and radiotherapy.肿瘤细胞对细胞毒性化疗和放疗的耐药性的临床意义。

Cytotechnology. 1993;12(1-3):385-91. doi: 10.1007/BF00744675.

Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.吸入卡波金并补充烟酰胺可改善患者肿瘤的氧状态。

Br J Cancer. 1995 Jul;72(1):198-205. doi: 10.1038/bjc.1995.303.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验